Thomas Jefferson University Hospital, Philadelphia, Pennsylvania, USA.
J Am Coll Cardiol. 2012 Oct 16;60(16):1540-5. doi: 10.1016/j.jacc.2012.07.017. Epub 2012 Sep 19.
This study sought to define contemporary trends in permanent pacemaker use by analyzing a large national database.
The Medicare National Coverage Determination for permanent pacemaker, which emphasized single-chamber pacing, has not changed significantly since 1985. We sought to define contemporary trends in permanent pacemaker use by analyzing a large national database.
We queried the Nationwide Inpatient Sample to identify permanent pacemaker implants between 1993 and 2009 using the International Classification of Diseases-Ninth Revision-Clinical Modification procedure codes for dual-chamber (DDD), single-ventricular (VVI), single-atrial (AAI), or biventricular (BiV) devices. Annual permanent pacemaker implantation rates and patient demographics were analyzed.
Between 1993 and 2009, 2.9 million patients received permanent pacemakers in the United States. Overall use increased by 55.6%. By 2009, DDD use increased from 62% to 82% (p < 0.001), whereas single-chamber ventricular pacemaker use fell from 36% to 14% (p = 0.01). Use of DDD devices was higher in urban, nonteaching hospitals (79%) compared with urban teaching hospitals (76%) and rural hospitals (72%). Patients with private insurance (83%) more commonly received DDD devices than Medicaid (79%) or Medicare (75%) recipients (p < 0.001). Patient age and Charlson comorbidity index increased over time. Hospital charges ($2011) increased 45.3%, driven by the increased cost of DDD devices.
There is a steady growth in the use of permanent pacemakers in the United States. Although DDD device use is increasing, whereas single-chamber ventricular pacemaker use is decreasing. Patients are becoming older and have more medical comorbidities. These trends have important health care policy implications.
本研究通过分析大型国家数据库,旨在确定永久性心脏起搏器使用的当代趋势。
自 1985 年以来,医疗保险国家覆盖决定(Medicare National Coverage Determination)中永久性心脏起搏器的单腔起搏强调一直没有重大变化。我们通过分析大型国家数据库来定义当代永久性心脏起搏器使用的趋势。
我们通过使用国际疾病分类-第九修订版-临床修正手术代码(International Classification of Diseases-Ninth Revision-Clinical Modification procedure codes),从 1993 年至 2009 年在全国住院患者样本中查询双腔(DDD)、单心室(VVI)、单心房(AAI)或双心室(BiV)设备的永久性心脏起搏器植入。分析了每年永久性心脏起搏器植入率和患者人口统计学特征。
1993 年至 2009 年间,美国有 290 万名患者接受了永久性心脏起搏器。总体使用率增长了 55.6%。到 2009 年,DDD 的使用率从 62%增加到 82%(p < 0.001),而单腔心室起搏器的使用率从 36%降至 14%(p = 0.01)。在城市非教学医院(79%)中,DDD 设备的使用率高于城市教学医院(76%)和农村医院(72%)。与医疗补助(Medicaid)(79%)或医疗保险(Medicare)(75%)受助人相比,拥有私人保险(83%)的患者更常接受 DDD 设备(p < 0.001)。患者年龄和 Charlson 合并症指数随时间推移而增加。医院收费(2011 美元)增加了 45.3%,这是由于 DDD 设备成本的增加。
在美国,永久性心脏起搏器的使用呈稳步增长趋势。尽管 DDD 设备的使用在增加,而单腔心室起搏器的使用在减少。患者年龄越来越大,且有更多的医疗合并症。这些趋势对医疗保健政策具有重要意义。